Anthem Establishes Coverage of C2N Diagnostics’ PrecivityAD2® Blood Test for Alzheimer’s Disease Evaluation - InsuranceNewsNet - 足球世界杯 March 14, 2018 05
Match Preview: In-depth Analysis *Medical policy marks a key commercial milestone as one of the nation's largest insurers recognizes the clinical importance of Alzheimer's blood biomarker testing*. C2N Diagnostics, LLC ("C2N"), a specialty diagnostics company with a vision to bring Clarity Through Innovation®, a
View Details